Next Generation Sequencing (NGS) Industry Analysis By Trends, Size, Share, Company Overview, Key Drivers, Top Players-Agilent Technologies, Inc., ThermoFisher Scientific, Inc., QIAGEN, Illumina

Understanding the segments helps in identifying The Latest research study released by DBMR "Global Next Generation Sequencing (NGS) Market" with 350+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. The importance of different factors that aid the market growth. The report shows market share, size, trends, growth, trends, applications, competition analysis, development patterns, and the correlations between the market dynamics and forecasts for 202 2to 2029 time-frames.

The global Next Generation Sequencing (NGS) Market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 17.1% in the forecast period of 2022 to 2029 and is expected to reach USD 29,307.13 million by 2029. Wide portfolio offered by major players and use of NGS in drug development is expected to act as driver for the next generation sequencing (NGS) market growth.

You Can Get a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market&ab

Market Analysis and Size

High-throughput sequencing, most widely regarded as the "next-generation" sequencing (NGS), is now integrated into routine clinical practice due to the numerous technical and functional developments, while early protocols relied on samples harvested outside of typical workflows in clinical pathology, standard formalin-fixed, paraffin-embedded specimens which can be used more regularly as starting material for NGS. In addition, protocols are being amassed for the analysis and interpretation of NGS data, as well as knowledge bases, allowing clinicians to act more easily on genomic information at the patient care point. The presence of wide range of products of the next generation sequencing used in the diagnosis of chronic diseases is satisfying the need of the healthcare facilities. The increased technological advancement leads to development of highly efficient next generation sequencing (NGS) in the market. 

Major factors driving the growth of global next generation sequencing (NGS) market are use of next generation sequencing in drug development and wide portfolio offered by major player and the factor which hampers the growth of the next generation sequencing (NGS) market includes high cost of next generation sequencing products and product recall.

Next Generation Sequencing (NGS) Market research report also provides the latest manufacturing data and industry future trends, allowing you to identify the products and end users driving profits growth and productivity. The Market report lists the most important competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, investigation and discussion of significant industry trends, market volume, market share estimates and profiles of the leading industry Players. Global Next Generation Sequencing (NGS) Market Research Report is providing exclusive vital statistics, information, data, trends and competitive landscape details.

Global Next Generation Sequencing (NGS) Market competition by TOP MANUFACTURERS, with production, price, and revenue (value) and market share for each manufacturer; the top players including:

Agilent Technologies, Inc., ThermoFisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Roche Sequencing (A subsidiary of F. Hoffman La Roche), BGI  (A subsidiary of BGI Group), Oxford Nanopore Technologies plc, MACROGEN CO., LTD., DNASTAR, Geneious, Partek, Incorporated, PerkinElmer Inc., Takara Bio Inc., bioMérieux SA, Pacific Biosciences of California, Inc.,  GENEWIZ, 10x Genomics, New England Biolabs, Hamilton Company among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

No. of Next Generation Sequencing (NGS) Market Report pages: 350

Scope of Report:      

The Market report lists the most important competitors and provides the insights strategic industry Analysis of the key factors influencing the market. This report will help you to establish a landscape of industrial development and characteristics of the Next Generation Sequencing (NGS) market. The Global Next Generation Sequencing (NGS) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, price, cost, revenue and gross margins.

Next Generation Sequencing (NGS) Market Scope and Market Size

The next generation sequencing (NGS) market is segmented on basis of product, application and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of product, the global next generation sequencing (NGS) market is segmented into instrument, consumables, and services. In 2022, the instrument segment is expected to dominate the global next generation sequencing (NGS) market as the instruments are the major component in next generation sequencing procedures.
On the basis of application, the global next generation sequencing (NGS) market is segmented into diagnostic, drug discovery, biomarker discovery, precision medicine, agriculture and animal research. In 2022, the diagnostic segment is expected to dominate the global next generation sequencing (NGS) market due to the fact that clinical laboratories have increasingly adopted the NGS for routine diagnosis because it has the potential to deliver precise test result and provide excellent treatment regime.
On the basis of end user, the global next generation sequencing (NGS) market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies. In 2022, research center and academic & government institutes is expected to dominate the global next generation sequencing (NGS) market as research related to next generation sequencing for chronic disease and personalized medicine is being conducted mainly by these institutes which is driving the segment growth.

The report also focuses on global major leading industry players of Global Next Generation Sequencing (NGS) Market providing information such as company profiles, product picture and specification, price, capacity, cost, production, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.

The Global Next Generation Sequencing (NGS) market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered. With tables and figures helping analyze worldwide Global Next Generation Sequencing (NGS) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Major Points Covered in Table of Contents: 

Global Next Generation Sequencing (NGS) Market Research Report 2022-2029, by Manufacturers, Regions, Types and Applications

Table of Contents

1 Study Coverage

2 Executive Summary

3 Market Size by Manufacturers

4 Next Generation Sequencing (NGS)Production by Regions

5 Next Generation Sequencing (NGS)Consumption by Regions

6 Market Size by Type

7 Market Size by Application

8 Manufacturers Profiles

9 Production Forecasts

10 Consumption Forecast

11 Value Chain and Sales Channels Analysis

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

13 Key Findings in the Global Next Generation Sequencing (NGS)Study

14 Appendix

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart)@ https://www.databridgemarketresearch.com/toc/?dbmr=global-next-generation-sequencing-ngs-market&Ab

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve."

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

This release was published on openPR.